Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Fresenius Medical Care AG & Co KGaA (NYSE: FMS).

Full DD Report for FMS

You must become a subscriber to view this report.


Recent News from (NYSE: FMS)

Portfolio Update: Stocks Getting Slammed As Dividends Shine Bright
My investment career is still very short (roughly 2.5 years) and as such the volatility we are now experiencing daily in the markets is certainly new to me. That said I have been actively watching how the stock markets behaved from 2007 - 2010 and although I am deeply regretting it not to have...
Source: SeekingAlpha
Date: December, 11 2018 10:45
Week In Review: China Pharmas Announce Deals Worth $1.5 Billion
Deals and Financings WuXi AppTec (SHA: 603259), China's largest CRO/CMO, completed a $1 billion IPO on the Hong Kong markets, pricing the offering in the middle of the expected range. In May, WuXi became a public company by completing a $328 million IPO in Shanghai. Since the offering, the...
Source: SeekingAlpha
Date: December, 10 2018 00:48
Fresenius down 10% premarket on softer guidance
Fresenius Medical Care (NYSE: FMS ) is down  10%  premarket on light volume following its statement that it does not believe its 2020 outlook is achievable considering its expectations for 2018 and 2019. More news on: Fresenius Medical Care AG & Co. KGAA, Healthcare stocks ...
Source: SeekingAlpha
Date: December, 07 2018 07:04
41 'Safer' Dividend Healthcare Pre-December WallStars From Dividend Dogcatcher
Source: YCharts Actionable Conclusions (1-10): Brokers Forecast Ten High Yield Top Healthcare 'Safer' Dividend Stocks to Net 12.6% to 26.75% Gains To November 2019 Four of ten top 'safer' dividend Healthcare stocks by yield (shaded in the chart above) were verified as being among the t...
Source: SeekingAlpha
Date: December, 03 2018 13:45
Healthcare Yields Of 3% To 4.8% From Top 10 WallStars In November
Actionable Conclusions (1-10): Analysts Projected 14.7% To 40.7% Net Gains For Top Ten Healthcare WallStars By November 2019 Five of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on broker 1-year target prices. ...
Source: SeekingAlpha
Date: November, 30 2018 11:58
Recent Analysis Shows LiveRamp, Five Point, Corporate Capital Trust, Fresenius Medical Care AG & Co. KGaA, Lsb Industries, and Telefonica Brasil S.A Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of LiveRamp Holdings, Inc. (NYSE:RAMP), Five Point Holdings, LLC (NYSE:FPH),...
Source: GlobeNewswire
Date: November, 20 2018 07:40
APC, NBL among premarket gainers
Daxor (NYSEMKT: DXR ) +13%  on contract from U.S. Army. More news on: Daxor Corp, Nano Dimension Ltd ADR, Foamix Pharmaceuticals, Stocks on the move, Top stock market news, , Read more ...
Source: SeekingAlpha
Date: November, 07 2018 09:28
Capital Square 1031 Completes Diversified DST Offering of Nine Medical Office Buildings in Five States
RICHMOND, Va. , Nov. 1, 2018 /PRNewswire/ -- Capital Square 1031, a leading sponsor of Delaware statutory trust investments, announced today that CS1031 Diversified Dialysis Portfolio, DST, comprised of nine medical office buildings in five states, has been fully subscribed by a to...
Source: PR Newswire
Date: November, 01 2018 09:00
Fresenius Medical Care AG & Co (FMS) CEO Robert Powell on Q3 2018 Results - Earnings Call Transcript
Fresenius Medical Care AG & Co (FMS) Q3 2018 Earnings Conference Call October 30, 2018, 10:30 ET Executives Dominik Heger - Head, IR & Corporate Communications Robert Powell - Chairman & CEO Michael Brosnan - CFO Analysts Veronika Dubajova - Goldman Sachs Group...
Source: SeekingAlpha
Date: October, 30 2018 18:44
Fresenius Medical Care AG & Co. KGAA 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by Fresenius Medical Care AG & Co. KGAA in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 30 2018 10:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1135.4934.7135.6534.521,475,546
2018-12-1035.3435.6535.7035.17574,501
2018-12-0735.8435.6735.9635.24749,471
2018-12-0639.0039.2339.2338.60304,781
2018-12-0441.7240.8441.7940.84443,507

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-118,36822,09837.8677Short
2018-12-107,87313,87356.7505Short
2018-12-0767,08994,28571.1555Short
2018-12-069,59022,20543.1885Short
2018-12-044,58812,60836.3896Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on FMS.


About Fresenius Medical Care AG & Co KGaA (NYSE: FMS)

Logo for Fresenius Medical Care AG & Co KGaA (NYSE: FMS)

Fresenius Medical Care is the world s largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than . million individuals worldwide. Through its network of , dialysis clinics in North America, Europe, Latin America, Asia Pacific and Africa, Fresenius Medical Care provides dialysis treatments for . patients around the globe. Fresenius Medical Care is also the world s leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.

 

Contact Information

 

 

Current Management

  • Ben A. Lipps / CEO
  • Lawrence A. Rosen / CFO
  • Heinz Schmidt / VP, Investor Rel.

Current Share Structure

  • Market Cap: $63,141,174,136 - 05/18/2018
  • Issue and Outstanding: 612,902,098 - 12/31/2017

 


Recent Filings from (NYSE: FMS)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: August, 01 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: July, 31 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: July, 05 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 29 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 29 2018
An annual report of employee stock purchase savings and similar plans
Filing Type: 11-KFiling Source: edgar
Filing Date: June, 29 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 12 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 04 2018
Specialized Disclosure Report
Filing Type: SDFiling Source: edgar
Filing Date: May, 30 2018
Amendment to a previously filed 6-K
Filing Type: 6-K/AFiling Source: edgar
Filing Date: May, 11 2018

 

 


Daily Technical Chart for (NYSE: FMS)

Daily Technical Chart for (NYSE: FMS)


Stay tuned for daily updates and more on (NYSE: FMS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: FMS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in FMS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of FMS and does not buy, sell, or trade any shares of FMS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/